During the past decade, Cherkassy Regional Oncological Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cherkassy Regional Oncological Hospital" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cherkassy Regional Oncological Hospital" are "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Cherkassy Regional Oncological Hospital" in a lesser frequency.

Most popular intervention types in "Cherkassy Regional Oncological Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cherkassy Regional Oncological Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cherkassy Regional Oncological Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cherkassy Regional Oncological Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cherkassy Regional Oncological Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".